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        Malaria is a protozoan disease caused in humans by four different species of the 
genus Plasmodium (P. falciparum, P. vivax, P. ovale, P. malarie) and in rodents by 
Plasmodium yoelii yoelii. It has been reported that 1.5 to 3 million deaths occur 
worldwide due to malaria and the DALY (Daily affected life years) reports about 0.76% 
of world population affected by the disease in some of the major countries like Africa, 
Asia, Latin America etc., Due to the development of resistance to drugs by the parasite, 
there is an urgent need and prime importance for the development of an effective vaccine 
against malaria. During its entire life cycle, the plasmodium sp. expresses various stage-
specific proteins that are considered potential candidates for vaccine development; the 
major ones belong to the (i) sporozoite, (ii) erythrocytic, (iii) gametocytic stages. 
Merozoite surface protein 1 (MSP1) is expressed on the surface of the parasite during the 
erythrocytic stage, which is considered as a potential vaccine candidate. The C-terminal 
portion of MSP1 is considered to be an effective vaccine candidate from inhibiting the 
parasite invasion into RBC.                 
     PyMSP119 has been expressed in plants via the chloroplast transformation. The site-
specific integration of PyMSP119  gene within chloroplast genome was confirmed by PCR 
using specific primers and the percentage of homoplasmy vs. heteroplasmy was 
confirmed by Southern blot. The expression of chloroplast-derived PyMSP119 plants was 
iii 
confirmed by western blot using anti- PyMSP119 antibodies. These experiments showed a 
17kDa protein under reducing conditions. The expression levels of PyMSP119 protein 
varied within transgenic plants were up to ~2% of total soluble protein (TSP) within 
mature leaves. To test the functionality of chloroplast-derived PyMSP119 protein, mice 
were immunized with the enriched chloroplast-derived PyMSP119 protein with Freund’s 
adjuvant. The immune response of anti- PyMSP119 antibodies were tested against 
standard PyMSP119 protein and it yielded 1:7000 IgG titers. The immunized mice were 
challenged with P.yoelii infected red blood cells (35-40% parasitemia) and the percentage 
parasitemia suggested an inverse correlation with the immune titers.  However, the 
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Malaria is a protozoan disease caused in humans by four different species of the 
genus Plasmodium (P. falciparum, P. vivax, P. ovale, P. malarie) and in rodents by 
Plasmodium yoelii yoelii. This disease is most widely prevalent in parts of Asia, Africa, 
central and south America, Oceania and certain parts of the Caribbean islands, causing 
1.5 to 3 million deaths; it has also been recorded that annually $12 billion has been spent 
on this disease in Africa alone (Breman JG et al., 2004). According to DALY report, 
0.76% of people are affected by malaria worldwide and the mortality rate is high among 
young children and pregnant women (http://www.who.int/en/). 
 
Life cycle of Plasmodium sp. and its pathophysiology 
 
         The female Anopheles mosquito transmits malaria from person to person. It acts as 
a host for the multiplication of plasmodium sp. When a mosquito bites a human, 
sporozoites in the mosquito’s saliva enter the blood circulation. P. falciparum is an 
obligatorily intracellular parasite within the human host. It first invades liver cells and 
then goes on to invade differentiated erythrocytes. The sporozoites migrate in the blood 
stream and reach the liver cells where they divide, multiply and mature in schizonts. 
Later the schizont ruptures to release the merozoites in the blood circulation. The 
merozoites then enter the RBC referred as the erythrocytic phase, where they undergo an 
asexual cycle of reproduction or develop into sexual forms known as gametocytes (Suh et 
al., 2004). The gametocytes then enter the gut of female anopheles mosquito during 
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ingestion of blood from the humans. Within the gut of mosquito, the micro and macro 
gametocytes differentiate into micro and macrogametes respectively, which eventually 
fuse to form a zygote, which then becomes a motile and invasive ookinete. The ookinete 
pierces through the wall of the gut and forms oocyst at the basal lamina of the gut wall. 
Here it multiplies numerous times and forms thousands of sporozoites which are then 
released. Later they migrate to the salivary glands, from there they enter the human host 
while feeding on the blood (Lingelbach et al., 2004). 
 
Clinical manifestations of Malaria 
 
          The most common symptoms experienced by malaria patients are fever, chills and 
headaches. Other common symptoms include dizziness, malaise, myalgia, abdominal 
pain, nausea, vomiting, mild diarrhea, and dry cough. Physical signs include fever, 
tachycardia, jaundice, pallor, hypotension, hepatomegaly, splenomegaly and anemia due 
to destruction of red blood cells. The complications of severe malaria include cerebral 
malaria, pulmonary edema, acute renal failure, severe anemia, and/or bleeding. Acidosis 
and hypoglycemia are the most common metabolic complications (Trampuz et al., 2003). 
All these symptoms reoccur for every attack and eventually patient becomes weak. If 
untreated, the effect of P.falciparum might lead to cerebral malaria where the patient 
goes to prolonged coma. The clinical manifestations of malaria in rodents are very much 
similar to human malaria affecting lungs, liver and spleen; the symptoms of cerebral 
malaria have also been shown (Medana et al., 2001). 
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Need for malaria vaccines 
 
         Commonly used drugs against malaria, such as chloroquine, primaquine, and 
artemisinin, are becoming ineffective due to the development of resistance by parasite. 
This could be due to mutation in the drug target, as a result, the drug no longer binds or 
recognizes the target and the other mechanism is to increase the expression of target 
either by enhancing the transcription and translation processes or amplify the gene, which 
makes the availability of drug as a rate limiting factor to inhibit the target 
(http://www.tulane.edu/wiser/malaria/fv.html). Therefore, there is an urgent need for an effective 
vaccine development to eradicate this problem. However, some major concerns for 
designing an effective malaria vaccine include  
(i) the  expression of antigen that is developmentally regulated; (ii) variation in the 
antigens of different parasite isolates; (iii) Individuals are non-responsive to certain 
parasite antigens or epitopes (Tine JA et al., 1996).  
 
Targets for Malaria vaccine 
 
            During invasion of RBC, the parasite exhibits various apical organelles like 
rhoptries, dense granules and micronemes (Preiser P et al., 2000, Sam-Yellowe, 1996). 
These help in proper penetration, adhering to the merozoite, re-orientating the apical end 
to get in contact with the cell, discriminating the host-cell, and ultimately forming a tight 
junction to penetrate into the cell (Barnwell et al., 1998). Specific interaction between 
parasite proteins and host-cell receptors occurs at all stages (Shahid et al., 2001) and 
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these stage-specific proteins are the major targets for vaccination. They are divided into 
(i) the pre-erythrocytic-liver stage, (ii) the asexual blood stage, and (iii) transmission-
blocking vaccines (Ya Ping Shi et al., 1999). The elicited immune responses by all these 
stage-specific proteins are equally complex, and result in humoral and cell-mediated 
responses (Weidanz and Long, 1987). 
           Therefore, the major focus of vaccine development is to identify an antigen or 
protein of value especially from asexual stage. Such antigens such merozoite surface 
protein, rhoptries which are on the surface of the infected red blood cell are considered to 
be effective, efficacious vaccine candidates (Ander et al., 1993). Attacking such target 
antigens would effectively curb the host pathogen interactions.  Proteins on the surface of 
the merozoites are considered to be targets of the immune response, which include 
merozoite surface protein 1 (MSP1; Cooper JA, 1993), MSP2 (Smythe et al., 1988) and 
Apical membrane antigen (AMA1; Peterson et al., 1989). 
 
Merozoite surface protein (MSP1) 
 
During schizogony stage, the precursor to the MSP1 protein is present on the 
surface of merozoites, which undergoes proteolytic processing (Holder, 1988). In 
P.falciparum, the molecular mass of MSP1 protein ranges from 185-250kDa and helps in 
erythrocytic invasion (Blackman et al., 1990). MSP1 in rodent malaria is about 230 kDa 
in size, and has been reported that the monoclonal antibody produced against the C-
terminal portion of this protein, was able to protect mice from parasite challenge (Spencer 
Valero et al., 1998). It has also been reported that the amino acid sequence of the rodent 
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merozoite surface protein has signal peptide, GPI sequence to adhere to the membrane, 
tandem repeats of tetrapeptides (Gly-Ala-Val-Pro) and the C-terminal portion with a 
series of 10 cysteine residues (Burns et al., 1988). At the amino acid level, the 193 kDa 
Plasmodium falciparum analogue shows an overall homology of approximately 30%, 
with 60% areas highly conserved (Lewis, 1989). The 230 kDa MSP1 protein undergoes 
proteolytic processing to 83 kDa during erythrocyte invasion (Cooper, 1993), which 
eventually gets cleaved to 16- 19 kDa protein (Blackman et al., 1990). It has been 
reported that the C-terminal portion of the 42 kDa fragment and the 16 to 19 kDa 
polypeptide subfragment (MSP1-19) are highly immunogenic and that the MSP1-mAb 
reacts with the reduction sensitive epitopes present on malaria parasites (Lyon et al., 
1987). On the basis of the merozoite inhibition assays, the C-terminal 19kDa protein has 
been proved to be a leading vaccine candidate antigen against blood stages of malaria 
(Blackman et al., 1990, Chappel and Holder 1993, Daly and Long 1993, Kumar et al., 
1995). The protective role for MSP119 – specific antibodies produced in response to 
infection or vaccination with recombinant proteins has been proved by conducting 
accurate quantification assays such as ELISA, IFA (O’Donnell et al., 2001, Saul et al., 
2001, De-Koning- Ward et al., 2003). In order to remove the non-specific inhibitory 
factors and increase the sensitivity to use minimal volumes of test serum, high- 
throughput inhibition assays for anti-malaria antibodies are being developed (Persson et 
al., 2006) 
        The 19 kDa C-terminal portion of MSP1 protein was found to be highly conserved 
among different isolates and among different species, with slight variation at four 
different amino acid positions (Lalitha et al., 1999). MSP1-19 has been expressed in E. 
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coli (Burghaus et al., 1994, Burns et al., 1989), yeast (Kaslow et al., 1994) and its 
immunogenic property has been studied in mice (Burns et al., 1989, Daly and Long 
1993) and monkeys (Kumar et al., 1995). It has also been shown in neutralization assays 
that anti-MSP119 antibodies inhibit the infection at blood-stage involving individuals 
naturally exposed to malaria, and they might correlate with the protection offered by 
MSP1-based vaccines in clinical trials (John et al., 2004). Oral immunization of mice 
with E. coli expressed C-terminal 19 kDa Plasmodium yoelii MSP1 induced 
immunoprotective levels of antibodies. However, immunization studies carried with the 
combination of two proteins (PyMSP1-19 and PyMSP4/5) conferred better protection as 
compared to that offered by either protein alone (Wang et al., 2004). Although the oral 
immunization studies have proven to be promising, the extensive purification and safety 
measures for E. coli or yeast- expressed proteins are always limiting factors. Therefore, 
an effective expression system that can provide a clean and safe vaccine is required. 
 
Plants for Malaria vaccine production 
 
         The alternative system for the expression of safe, efficacious malaria vaccine 
antigen is considered to be plants. The plant expression system may be ideal for 
producing vaccines since, large amounts of vaccine can be produced at low cost. Plants 
can ensure proper post-translational modification as seen in higher organisms (Ma et al., 
1995). Therefore, plants are used for expressing various vaccine antigens. Malaria 
epitopes have been expressed in plant viruses like TMV (tobacco mosaic virus) (Turpen 
et al., 1995) and the C-terminal portion of MSP1 of Plasmodium falciparum has also 
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been expressed via nuclear transformation in tobacco with expression levels up to 
0.0035% of TSP (Ghosh et al., 2002). Such low expression levels of this protein 
prevented further functional studies. Therefore, an effective, alternative approach is 
needed to enhance the expression levels and also to ensure proper conformation of 
MSP119 protein to be functional. 
 
Chloroplast genetic engineering 
 
The chloroplast transformation technology unfolded in the 80s (Daniell and 
Dhingra, 2002). One of the very first chloroplast genome complementation was reported 
in the unicellular green alga Chlamydomonas reinhardtii having a single chloroplast 
(Boynton et al., 1988). The photosynthetic mutants lacking the atpB gene were 
complemented by targeting the atp gene into chloroplast genome via homologous 
recombination (Klein et al., 1987).  
The integration of uidA gene encoding the beta glucoronidase flanked by 
chloroplast DNA sequences in the C. reinhardtii chloroplast genome was shown; 
although no protein expression was observed (Blowers et al., 1989). Hence, the 
chloroplast technology has been extended to higher plants by introducing foreign genes 
into isolated plastids (Daniell and McFadden, 1987).  
Chloroplast transformation with the foreign genes was done transiently by 
culturing the plastid cells of tobacco using autonomously replicating chloroplast vectors 
(Daniell et al., 1990), which was further extended to wheat leaves, calli and somatic 
embryos (Daniell et al., 1991). However, the major breakthrough was the introduction of 
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spectinomycin or streptomycin resistant gene coded by aadA into the chloroplast genome 
of the C. reinhardtii (Goldschmidt-Clermont, 1991).  
After the successful integration of selectable marker gene and isolating the 
transformants under selection, the focus was laid on optimizing the expression protocols. 
At the beginning, the foreign genes were targeted into the transcriptionally silent spacer 
regions of the chloroplast genome (Zoubenko et al, 1994). Later, the transgenes were 
inserted in transcriptionally active spacer regions (Daniell et al., 1998). The introduction 
of multigene operon (Quesada et al., 2005) has facilitated the expression of several 
agronomic traits, biopharmaceutical proteins and vaccines (Chebolu et al., 2005, Grevich 
et al., 2005). Majority of therapeutic proteins have been expressed in tobacco such as 
human interferon (Daniell et al., 2004a, Leelavathi and Reddy et al., 2003), human 
somatotropin (Staub et al., 2000) and human serum albumin (Fernandez et al., 2003). 
Recently the technology has been extended to other commercial crop species such as 
carrot, cotton, tomato, potato, soybean and lettuce by transforming the plastids (Kumar et 
al., 2004a, Kumar et al., 2004b, Ruf et al., 2001.; Sidorov et al., 1999; Dufourmantel et 
al., 2004, Kanamoto et al., 2006, respectively). 
The genetic manipulation is quite amenable in tobacco plant and also yields 
enormous biomass (40 tons fresh leaf weight/acre biomass per season). The tobacco plant 
is produces seeds in large numbers (up to one million seeds produced per plant). The 
chloroplast technology has been well exploited in tobacco by expressing various vaccine 
antigens and therapeutic proteins. A monoclonal antibody Guy’s 13, against 
Streptococcus mutans has been expressed via the chloroplast transformation (Daniell et 
al., 2001b).  
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Some of the agronomic traits have been studied via chloroplast technology such 
as insect resistance (Bacillus thuringiensis (Bt), the Cry2Aa2 protein), which reported the 
highest protein expression of up to 46.1% tsp to date (DeCosa et al., 2001), herbicide 
resistance against Glyphosate(EPSPS gene; Daniell et al., 1998), the antimicrobial 
peptide MSI-99, an analog of magainin (De gray et al., 2001), which inhibited growth of 
Pseudomonas aeruginosa, multi-drug resistant bacteria and Pseudomonas syringae, a 
major plant pathogen (DeGray et al. 2001, Devine and Daniell, 2004, Daniell et al., 
2004a), drought tolerance (the yeast trehalose phosphate synthase (TSP1); Lee et al., 
2003), salt tolerance in carrot(BADH gene; Kumar et al., 2004a).Also, the cytoplasmic 
male sterility (Ruiz et al., 2005) eliminates the transfer of foreign gene via the chloroplast 
transformation. 
 
Vaccine antigens Expressed Via the Chloroplast Genome
 
            The advantages of expressing vaccine antigens in the chloroplast genome are: 
expression of subunit peptides that are non-toxic and do not multiply; due to the 
prokaryotic nature of chloroplast, the bacterial genes with AT content are expressed at 
high levels in the chloroplast; and oral delivery of vaccines induces high mucosal and 
high systemic responses, and helps the system to combat against germs at portals of 
entry. Some of the vaccines that have already been expressed in the chloroplast include 
C-terminus of Clostridium tetani (TetC) (Maliga P, 2003), the Cholera toxin B-subunit 
(CTB), which does not contain the toxic component that is in CTA (Daniell et al. 2001a), 
the 2L21 peptide from the Canine Parvovirus (CPV) (Molina et al., 2004), F1~V fusion 
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antigen for plague (Singleton et al., 2003), the protective antigen of Bacillus anthracis 
without lethal and edema toxins (Watson et al 2004, Koya et al., 2005), Lec A antigen for 
amebiasis (Chebolu et al., 2006), NSP4 protein for rotavirus vaccine (Kalluri et al., 
2005). The expression levels of CTB was up to 4 to 31% of Total Soluble Protein (TSP) 
and the GM1-ganglioside binding assays have shown the proper folding and formation of 
disulfide bonds in chloroplast-derived CTB to form functional pentamers that recognized 
the GM1 receptors (Daniell et al. 2001a, Molina et al., 2004). The anthrax protective 
antigen (PA) was expressed at a maximum value of 14.2% TSP and at this rate, 360 
million doses of anthrax vaccine could be obtained from an acre of land, which is 
sufficient for the entire U.S. population (Koya et al., 2005). The protective antigen of 
Bacillus anthracis expressed in tobacco chloroplast was shown to be immunoprotective 
in mice immunized with purified PA83 derived from tobacco chloroplasts along with 
adjuvant (Koya et al., 2005). The intranasal delivery of chloroplast-derived TetC 
produced both IgG and IgA and shown to be immunoprotective against toxin challenge 
(Tregoning et al., 2003). The expression levels of chloroplast-derived 2L21 peptide from 
Canine Parvovirus (CPV) fused to GFP showed up to 22% of TSP, and that fused to CTB 
showed up to 31% TSP (Molina et al., 2004).  
 
Bioencapsulation for the oral delivery of vaccine antigens and protection of 
immunogens in the alimentary tract 
 
        The oral delivery of pharmaceutical proteins into the body can be successful if the 
intact protein can be delivered without degradation by the digestive enzymes present 
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within the stomach. The ability to protect the protein against digestive juices is referred to 
as bioencapsulation (Walmsley and Arntzen, 2000; Yu and Langridge, 2001). The 
nuclear expression of Heat-labile enterotoxin B-subunit (LTB) from E. coli in tobacco 
and potato yielded <0.01% Total soluble protein and 0.19% TSP respectively. When 
administered orally, the LTB expressed in potato was found to be immunoprotective. 
Although expressed in lower amounts, the antigens expressed in tobacco were 
immunogenic (Haq et al., 1995, Mason et al., 1996, Tacket et al., 1998). Another vaccine 
antigen for Norwalk vaccine (the capsid protein) expressed in potato and tomato via the 
nuclear transformation was immunogenic, when delivered orally (Mason et al., 1996, and 
Richter et al., 2000, Tacket et al., 2000). The nuclear expression of the envelope surface 
protein of hepatitis B virus in tobacco, potato and lupin yielded less than 0.01% fresh 
weight but were immunogenic, though not protective when administered orally (Richer et 
al., 2000, Kapusta et al., 1999). These findings prove that the higher expression level of 
therapeutic proteins is required in plants to observe the therapeutic effects. When given 
orally, IFN-alpha showed biological activity in humans and other animals (Bocci 1999). 
Commercial and native animal trials have been done with plant-derived edible vaccines 
(Castanon et al., 2000, Tuboly et al., 2000). Therefore, the concept of bioencapsulation is 
important in protecting these vaccine antigens against digestive enzymes and ensures 
their biological activity. As a result, the chloroplast technology is currently being 
extended to other edible crop species such as potato, tomato, carrot and soybean (Sidorov 
et al., 1999, Ruf et al., 2001, Kumar et al, 2004a, Dufourmantel et al., 2004) for oral 
delivery.  
The oral delivery of the foreign proteins expressed in chloroplast needs to be 
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delivered intact into the body for the complete therapeutic effect. Crossing the mucosal 
barrrier and resisting the acid digestion are the prime limiting steps for the oral delivered 
therapeutic proteins. For this a prototype molecule CTB-GFP molecule was designed and 
expressed in tobacco chloroplasts. Chloroplast-derived GFP was given orally to evaluate 
the transmucosal carrying ability and bioencapsulation of the chloroplast derived 
proteins.  The Chloroplast-derived CTB acts as a transmucosal carrier by binding the 
GM1 ganglioside and also the protein molecule was protected from peptidases and/or 
acids by bioencapsulation within the plant cells. The rapid turnover of intestinal epithelial 
cells (Heath, 1996) for recycling GM1 receptors makes this approach a reality (Limaye et 
al., 2006), thus creates an opportunity for the cheaper production and delivery of human 
therapeutic proteins. Recent reports on complete chloroplast genomic analysis of 
different crop species like grape (Jansen et al., 2006), cotton (Lee et al., 2006), potato & 
tomato (Daniell et al., 2006), legume crops like soybean (Saski et al., 2005), carrot 
(Kumar et al., 2004), lettuce (Kanamoto et al., 2006), etc., provide the basic 
understanding of chloroplast genome in different species. This information might help in 
designing appropriate vectors containing the plant regulatory sequences and also optimize 
the tissue regeneration on the growth media after the post bombardment (Tissue 
regeneration) for these crops, stepping towards the oral delivery. 
 
Advantages of Chloroplast Expression versus Expression in E. coli 
 
The major disadvantages with E.coli expression system over chloroplast 
expression system are as follows: 1) E.coli system involves expensive steps for the 
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production of recombinant proteins in microorganisms, demands stringent purification 
protocols and requires costly fermenters. All these problems can be overcome by vaccine 
production in plants, which involves a straightforward farming, fairly inexpensive, and 
can lower the cost in one season.  
2) When compared with E.coli fermentation expenses, the production cost for 
recombinant proteins in tobacco is 10 to 50 times cheaper (with 20% expression levels in 
E. coli, Kusnadi et al., 1997). 
          3) The existing technologies for harvesting, storage, and purification of transgenic 
plant proteins, keeps the plant proteins within transgenic lines protected. 
4) The risk of contamination with bacterial and animal pathogens is eliminated 
from plant-derived vaccines because the plants do not serve as host for humans pathogens 
unlike the bacterial and animal systems. 
Furthermore, chloroplasts are meant to maintain the integrity of the expressed 
protein i.e., they ensure proper folding of proteins and maintain their natural 
conformation with correct disulfide bond formation (as seen in CTB; Daniell 2001a). The 
GM-1 ganglioside binding assays demonstrated that chloroplast-synthesized CTB is 
correctly folded with required disulfide bonds as it forms the pentameric stucture, which 
recognizes the GM-1 ganglioside receptors. The immunogenic properties of many 
chloroplast-derived vaccine antigens have been proven (Tregoning et al., 2003, Molina et 
al., 2004, Koya et al., 2005).   
      Also, the expensive purification process of recombinant protein produced in E. coli is 
the limiting factor. For example, the overall insulin production accounts for 30% of the 
production cost and 70% of the set-up cost (Petrides et al. 1995). Although, the 
13 
transformed tobacco plants require purification processes but the production of edible 
vaccine in carrot or tomato would eliminate this step and so are the expenses for delivery 
of vaccine. Therefore, extending the production of protective Antigen in carrot plastids 
for oral vaccination would be ideal.  
 
Advantages of Chloroplast Transformation over Nuclear Transformation 
 
Due to the maternal inheritance of transgenes in chloroplast transformation, the 
major concern of cross-pollination from genetically modified crops to wild type crops is 
eliminated. Thus, the transgene containment is ensured by the property of maternal 
inheritance (Daniell, 2002, Daniell and Parkinson, 2003).  
For the commercial availability, the transgene expression in plants must be greater 
than 1% (Kunsnadi et al., 1997). Nuclear transformation of plants has usually produced 
lower expression levels of antigens (Daniell et al., 2001a, May et al., 1996, Richter et al., 
2000, Tacket et al., 2000, Ramirez et al., 2003, Devine and Daniell, 2004, Daniell et al., 
2004b, Daniell et al., 2004c). The oral delivery of vaccine demands high expression of 
the protein to elicit adequate immune response. Therefore, an alternative approach such 
as chloroplast transformation has been adopted, which yields high protein expression 
levels due to an increased number of chloroplast genomes per cell (up to 10,000). This 
results in high transcript and abundant translated product of the gene of interest (up to 
47% of Cry2Aa2 ;DeCosa et al., 2001).  
The site-specific integration of gene by homologous recombination in chloroplast 
eliminates position effect and gene silencing as opposed to nuclear transformation 
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(Grevich and Daniell, 2005).. In nuclear transformation, the random integration of 
transgene results in unstable and inconsistent gene expression or complete loss of 
transgenic activity due to insertion of regulatory sequences in a repetitive pattern. Also, 
the random recombination results in variable levels of transgene expression (position 
effect) and gene silencing (Fagard and Vaucheret, 2000). A very high accumulation of 
transcripts (169-fold higher than nuclear transgenic lines) has shown no gene silencing 
(Lee et al., 2003, Dhingra et al., 2004). Similarly, no gene silencing was seen at the 
translational level regardless of the accumulation of foreign protein up to 47% TSP 
(DeCosa et al., 2001). Another major advantage of chloroplast genetic engineering is the 
ability of chloroplast to transcribe operons and translate the polycistronic mRNA. 
(DeCosa et al., 2001, Ruiz et al., 2003, Daniell and Dhingra, 2002, Lossl et al., 2003, 
Quesada-Vargas et al., 2005). 
 
Advantages of Producing the Malaria Vaccine in Plant Plastids 
 
1. No human or animal pathogen contamination has been reported in plant expressed 
proteins due specific Pathogen-host specificity (Streatfield et al., 2001). Therefore, 
PyMSP119 protein in plants would yield a vaccine free of pathogens. 
2. The PyMSP119 antigen genes have an A/T content of 65.14%, suitable for prokaryotic 
environment of chloroplast. 
3. Chloroplast ensures proper folding of the protein with correct disulfide bonds as it has 
protein disulfide isomerases and thioredoxins (Kim et al., 2003). It has been shown in 
earlier studies such as CTB (DeCosa et al., 2001,) at 33% TSP (Daniell et al., 2001a), 
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the Human serum albumin (Fernandez-San Millan et al., 2003), Interferons 
(Leelavathi and Reddy, 2003, Daniell et al., 200). Thus, the expression of PyMSP119 
in chloroplast genome would ensure proper disulfide bond formations. 
4.  The PyMSP119 antigen is not glycosylated, which is good for our particular system 
because plastids do not glycosylate proteins.  
5. Plants have up to 100 chloroplasts per cell, each containing about 100 chloroplast 
genomes. This provides up to 10,000 genomes per cell to efficiently produce the 
antigens. 
6. Chloroplast eliminates cross-pollination of the transgene because of being maternally 
inherited (Daniell, 2002, Daniell and Parkinson, 2003). 
7.  Gene silencing and position effect is eliminated due to the integration of trangenes in 
the intergenic spacer sites of the chloroplast genome (Daniell et al., 2002; Grevich 
and Daniell, 2005). 
8.  Bioencapsulation has ensured protection of vaccine antigens in the stomach and has 
also proven to be immunogenic when administered orally in clinical trials (Tacket et 
al., 1998, Kapusta et al., 1999, Tacket et al., 2000, Castanon et al., 2000, Tuboly et 
al., 2000, Walmsley and Arntzen, 2000, Tacket et al., 2003 Tacket et al., 2004).  
9. The success of producing vaccine antigens in tobacco could be extended to other 
edible crop species such as carrot and tomato. Delivery of plant-derived vaccine to 
mucosal tissues has been shown to induce both mucosal and systemic immune 
responses (Haq et al.1995., Mason et al.1996, Arakawa et al., 1998). Mucosal 
immunization may give higher protection from aerosolized spores of anthrax by 
producing s-IgA in the mucosal system. 
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RATIONALE AND APPROACH 
 
The primary objective of the project is to express and characterize PyMSP119 
protein in tobacco chloroplast followed by the evaluation of the immunogenicity of 
chloroplast-derived PyMSP119 protein in the mouse model. If the protein is immunogenic 
in nature, their ability to inhibit the parasite invasion of RBC will be tested. To achieve 
these goals, transgenic lines had to be obtained that express PyMSP119 protein with 
correct folding and proper disulfide bond formation required for its native conformation 
and formation of epitopes. Since the chloroplast cell has protein disulfide isomerases and 
thioredoxins (Kim et al., 2002), which facilitated the disulfide bond formation in various 
vaccine antigens expressed earlier (CTB; Daniell et al 2001, Human interferon; 
Leelavathi and Reddy 2003, Human serum albumin; Fernandez et al., 2003, Human 
somatotropin; Staub et al., 2000) we decided to express PyMSP119 protein in the 
chloroplast genome under similar assumptions. The strategy for primer designing and 
performing polymerase chain reaction using primers to introduce PyMSP119 gene is as 
described in Materials and Methods section (page 43). The bacteriophage g10 5’UTR 
with no promoter but a ribosomal binding region ensures the translation of PyMSP119 
protein, is introduced upstream the gene of interest. The PyMSP119 gene is transcribed 
under the control of prrn promoter present upstream the gene. The gene product will be 
confirmed and purified. The purified protein will then be evaluated for its immunogenic 
property in the mouse system. If successful, the mice will be challenged with the parasite 
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P.yoelii to observe the protection offered against the infection by chloroplast-derived 
PyMSP119- specific antibodies. 
 
MATERIALS AND METHODS 
General protocols
Preparation of Ultracompetent cells (Rubidium Chloride Method) 
        The ultracompetent cells were prepared by using rubidium chloride method 
(http://www.neb.com/nebecomm/tech_reference/protein_expression) from XL1 MRF 
Blue (Stratagene). From E.coli glycerol stock , some culture is taken and  streaked on the 
LB agar plate containing 12.5 µg/ml tetracycline and incubated at 37°C overnight . The 
next day, a single colony is grown in 5 ml Psi broth with 12.5 µg/ml tetracycline and 
incubated at 37°C at 225rpm for 12-16 hr in a horizontal shaker. About 1 ml of the 
culture was inoculated in 100 ml of Psi broth and incubated in  37°C shaker for 2 hours  
at 225rpm. After two hours, the optical density (O.D) was checked at 550 nm for two 
hours and subsequently for every 30 to 60 minutes until it reached 0.48 O.D. Later, the 
culture was kept on ice for 15 minutes and centrifuged at 3000g/5000 rpm for 5 minutes 
in a sorvall centrifuge. The pellet was resuspended in 0.4 volume (40 ml) of ice cold 
TFB-I solution, discarding the supernatant. The centrifugation step was repeated, 
followed by resuspension of cells in 4 ml of TFB-II solution and kept on ice for 15 
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minutes. Finally, the suspension aliquoted into 100 µl and freezed in dry ice/liquid 
nitrogen to be stored at - 80°C. 
Transformation of Competent E. coli XL1-Blue cells 
       Competent cells prepared as above (100 µl aliquots) were taken from -80°C and 
thawed on ice to transfer to a falcon tube. About one μl (100 ng) of plasmid DNA was 
added to the cells and the mixture was incubated on for 30 minutes on ice with a gentle 
mixing after first 15 min. Then heat shock treatment was given at 42°C in a water bath 
for 90 to 120 seconds and kept on ice for two minutes. Later, the cells were incubated 
with 900 µl of LB broth at 37oC horizontal shaker for 45min at 225 rpm. The cells were 
centrifuged at 13,000 rpm for 30 seconds. The supernatant with 900 μl was discarded and 
remaining 100μl of cells were resuspended. The cell suspension was spread on agar plate 
with selection media in two different volumes i.e., 50µl and 100μl..  
Isolation of Plasmid DNA by Alkaline lysis 
The colonies were picked from the LB-agar plate and grown in LB-culture with 
selection media for 12-16hrs at 37oC shaker. The grown culture is taken into an 
eppendorf tube at 1.5ml volume and centrifuged at 13,000 rpm for 1 minute. The pellet 
was resuspended in 150 μl of Solution I (GTE: 50 mM Glucose, 10 mM EDTA, 25 mM 
Tris, pH- 8) after discarding the supernatant. Each tube was added with 1 μl of RNase 
(100 mg/ml). Later, 150μl of Solution II (0.2N NaOH, 10% SDS) was added to each tube 
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and mixed gently by inverting the tube 6 times. After that, Solution III (60 ml of 5M 
Potassium Acetate, 11.5 M glacial acetic acid, 28.5 ml sterile dH2O) was added in the 
same volume and mixed gently for 6 times. Then, the mixture was centrifuged at 13,000 
rpm for 10 minutes at 4°C followed by, transfer of supernatant into a fresh eppendorf 
tube with care to exclude white debris (i.e., bacterial chromosomal DNA/SDS/membrane 
proteins). Then, the plasmid DNA was pelleted by adding 900 μl of ice cold, ethanol 
(95%) and centrifuged at 13,000 rpm at 4°C for 10 minutes. The supernatant was 
removed and discarded, without disturbing the plasmid DNA pellet at the bottom. Further 
washing of the pelleted DNA was done using 400μl of 70 % chilled ethanol and (without 
mixing) centrifuged for 5 minutes. Subsequently, the pellet was dried in the speedvac on 
medium heat for 3-5 minutes and resuspended in TE (pH 8.0). The concentration and the 
quality of plasmid DNA was measured by spectrophotometer. The isolated plasmid DNA 
was run on a 0.8% agarose gel for 40 minutes at 80 volts to confirm the successful 
isolation of plasmid (Sambrook et al., 1989). 
 
Construction for pLD-g10-PyMSP119 vector for transformation of tobacco 
Chloroplast 
 
       Nde1 and NotI restriction sites were introduced by polymerase chain reaction on 5’ 
and 3’end of pRTL vector with PyMSP119 by using primers: Forward 5’-
GCCCaTATGGATGGTATGGAT-3’(engineered Nde1 site) and Reverse 5’- 
TCAgCggccgCtCaGCTGGAGGA-3’ (engineered stop codon and Not1 site) (Invitrogen). 
The plasmid pRTL with PyMSP119 was used as template to obtain the PCR product of 
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size 313 bp containing Nde I restriction site at the 5’end and NotI restriction site at the 3’ 
end. For a 50 µl reaction volume, the PCR was set as follows: 100 ng of plasmid DNA, 5 
μl of 10X pfu buffer, 5 μl of 2.5 mM dNTP, 1 μl of each 10 mM primer, 0.5 μl pfu DNA 
polymerase and H2O to make up the final volume. The PCR cycle was set up for 25 
cycles as follows: 94°C for 30 sec, 55°C for 30 sec, and 72°C for 30 sec. The 
denaturation step was for 5 min at 94°C and followed by a final extension for 10 min at 
72°C. The PCR product of 5 μl each including controls were loaded onto a 0.8% agarose 
gel. The amplified PCR product was purified using PCR purification kit (Qiagen). The 
phosphate groups were added to the PCR fragment to the 5’ ends of both strands and 
cloned into EcoRV restriction site of digested and dephosphorylated p-Bluescript plasmid 
vector. The positive clone was isolated by alkaline lysis miniprep and was sequenced 
using M13 forward (5’-TGACCGGCAGCAAAATG-3’) and M13 reverse 
(5’GGAAACAGCTATGACCATG-3’) primers. The PCR product was digested from 
ligated p-Bluescript-PCR product with NdeI and NotI and cloned into pCR2.1 vector 
containing the g10-5’UTR with NdeI and Not1I (fragment size approximately 313 bp). 
Finally, the pCR2.1 containing the g10-5’UTR, PyMSP119 was digested with XbaI 
(fragment size approx. 345bp) and cloned into tobacco universal vector pLD-ctv. 
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 Bombardment of the pLD-g10- PyMSP119
Preparation of gold particles 
A mixture containing 50 mg of gold particles (0.6 μm in size) and 1 ml of 70% 
were vortexed for 3 to 5 minutes and then incubated for 15 minutes at room temperature. 
The gold particles were pelleted by centrifugation and the supernatant was discarded. 
Then the particles were vortexed with 1 ml of distilled water followed by a pulse 
centrifugation for 3 seconds; the supernatant was discarded. This step was repeated three 
times (Kumar and Daniell, 2004). 
Preparation of tobacco tissue culture media 
For regeneration and selction of transgenic plants, RMOP media containing MS 
basal salt mixture (one pack), 30 g of sucrose, 100 mg of myo-inositol, 1 ml of 
benzylaminopurine (BAP: 1 mg/ml), 100 μl of α-naphtalene acetic acid (NAA: 1 mg/ml), 
1 ml of thiamine hydrochloride (1 mg/ml), and water (to 1 liter) was prepared and 
adjusted pH to 5.8 using 1N KOH. To solidify the media, 6g/ liter of phytagar was added 
to the media and autoclaved. The cooled media was poured into plates. For rooting, MSO 
media containing 30 g sucrose, 1 packet of MS basal salt mixture, and water to 1 liter was 
prepared with 5.8 pH using 1N KOH and 6 g per liter of phytagar (Kumar and Daniell, 
2004). 
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Bombardment protocol for tobacco leaves 
The bombardment was performed as described previously (Daniell, 1997). Under 
sterile conditions, the bombardment of tobacco leaves was done. All the equipment was 
sterilized either with 95% ethanol or autoclave. The gold particles (Fifty μl) were placed 
in a micro centrifuge tube followed by 10 μl of DNA (1 μg/μl). Fifty μl of 2.5 M CaCl2 
and 20 μl of 0.1 M spermidine-free base were added sequentially to the mixture to ensure 
proper binding of DNA to the gold particles. The mixture was then vortexed for 20 
minutes at 4°C to ensure proper binding of the DNA with the gold particles. This was 
followed by washing four times in 200 μl of absolute ethanol at 3,000rpm for 30 seconds. 
The DNA with the gold particles was resuspended in 30 μl of 100% ethanol. Green 
healthy leaves from the aseptic tobacco plant Nicotiana tabacum variety Petit havana 
were cut from a young plant growing in jars containing MSO media and placed on a Petri 
dish (100 x 15 mm) containing RMOP media with no selection and a Whatman filter 
paper on the top of media. The leaves were placed with the abaxial side upwards. The 
gene gun (Bio-Rad PDS-1000/He) was sterilized with 70% ETOH prior to bombardment. 
The macrocarriers were placed on the macrocarriers holders. The gold particles lying on 
ice were vortexed and 5 μl of gold particles containing the DNA were placed on top of 
the macro carrier. Vortexing is an important step while placing the gold particles on the 
macrocarriers. The bombardment was carried on at 1,100 psi and 28 Hg. After the 
bombardment, the samples were covered with aluminum foil (to keep them in the dark) 
and incubated for 48 hours at room temperature. (Kumar and Daniell, 2004). 
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Tissue regeneration and selection 
 
 After 48 hrs of allowing the leaf tissue to recover, the leaves were cut into 5x5 
mm2 size and were transferred to RMOP media containing 500 μg/ml of spectinomycin 
(Daniell, 1997). After four to six weeks, confirmed positive transgenic lines by PCR 
analysis were subjected to second round of selection in a similar fashion. Finally, after 4 
weeks on secondary selection, the shoots were transferred to a jar that contained MSO 
media with 500 μg/ml spectinomycin (Daniell, 1997). This accounts for the third round 
of selection. (Kumar and Daniell, 2004). 
 
Plant genomic DNA extraction procedure 
 
The Qiagen DNeasy Kit was used to isolate plant genomic DNA as described in 
the Qiagen manual. 100 mg of the leaf tissue was ground in a micro centrifuge tube, 
using a micro pestle in 400 μl of buffer AP1 and 4 μl of RNase A (stock solution 
100mg/ml). The mixture was incubated for 10 minutes at 65°C and mixed 2-3 times. 130 
μl of buffer AP2 were added to the lysate, vortexed and incubated for 5 minutes on ice. 
The mixture was centrifuged at maximum speed for 5 minutes and the supernatant was 
transferred to a Qiashredder spin column (lilac) sitting in a 2 ml collection tube. The 
centrifugation was performed at full speed for 2 minutes. The flow through was collected 
in a new tube and 1.5 volumes of buffer AP3/E were added to the lysate and mixed 
immediately. 650 μl of this mixture was applied to a DNeasy mini spin column (clear) 
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and centrifuged for 1 minute at 8000 rpm. The flow through was discarded and the step 
was repeated with the rest of the sample. The collection tube was discarded and the 
column was placed in a supplied 2 ml tube. Buffer AW (500μl) was added to the column 
and centrifuged for 1 minute at 8,000 rpm. The flow through was discarded, and the 
column was washed once again by using 500 μl of AW buffer followed by centrifuging  
for 2 minutes at maximum speed. The column was transferred to a clean 1.5 ml tube and 
100 μl of preheated (65°C) buffer AE was added into the DNeasy membrane. The 
membrane was incubated for 5 minutes at room temperature and then centrifuged at 
8,000 rpm for 1 minute to elute the DNA. The DNA was stored at -20°C. 
 
Confirmation of transgene integration into the chloroplast genome 
 
To confirm transgene cassette integration into the chloroplast genome, PCR was 
performed using the primer pair 3P (5’-AAAACCCGTCCTCEGTTCGGATTGC-3’) and 
3M (5’-CCGCGTTGTTTCATCAAGCCTTACG-3’) (Daniell et al., 2001a). Also, the 
integration of gene of interest by PCR was performed using primer pair 5P (5’-
CTGTAGAAGTCACCATTGTTGTGC-3’) and 2M (5’-TGACTGCCCACCTGAGAG-
CGGACA-3’) (Daniell et al., 2001a). Positive (known transgenic plant DNA sample) and 
negative controls (wild type petit havana DNA sample) were also used. For a 50 μl 
reaction volume, the PCR was set as follows: 150 ng of plant DNA, 5 μl of 10X buffer, 4 
μl of 2.5 mM dNTP, 1 μl of each primer from the stock, 0.5 μl Taq DNA polymerase and 
H2O to make up the total volume. The amplification was carried out for 25 cycles of the 
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following program: 94°C for 30 sec, 65°C for 30 sec, and 72°C for 2 min.  Denaturation 
was done for 5 min at 94°C at the start and a final extension of 7 min at 72°C was carried 
on at the end. 5 ul of each PCR products including the controls were loaded into a 0.8% 
agarose gel to confirm the results. 
 
Southern blot analysis of transgenic plants 
Restriction Digestion of plant genomic DNA 
Total plant genomic DNA was extracted from both transgenic T0 as well as 
untransformed tobacco plants. The samples containing equal quantity of DNA were 
digested with BglII in a reaction containing: 2 ug of DNA, 3 μl of 10X buffer (New 
England Biolabs), 1.5 μL of BglII enzyme (New England Biolabs) and sterile dH2O to 
make up the volume of 30μl. The reaction was incubated overnight at 37°C.  
Agarose electrophoresis and DNA transfer 
A total of 20 μl reaction volume was loaded on a 0.7% agarose gel for each of the 
transgenic plant DNA samples. The digested DNA of wild type plant (Nicotiana tabacum 
var. Petit Havana) acts as negative control and the unlabelled probe acts as the positive 
control. Electrophoresis was carried on for 2.5 hours at 50 volts following which, the 
DNA was transferred by capillary action to a nylon membrane. The parts of the gel that 
were not needed were removed, and the upper right corner was cut to help as a guide. The 
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gel was then depurinated by immersing it in 0.25 M HCl (depurination solution) for 15 
minutes (until the color of the dye became yellow). This was followed by washing the gel 
twice in dH2O for 5 minutes, and then equilibrated in transfer buffer (0.4N NaOH, 1M 
NaCl, filled to 1 liter with water) for 20 minutes. Whatman paper and the nylon 
membrane were cut to fit the size of the gel. The membrane was briefly washed in water. 
Later, the membrane was equilibrated by immersing it in the transfer buffer for 5 
minutes. In a glass tray, a stack of two sponges was placed and enough transfer buffer 
was added to cover the sponge that is in touch with the tray. On top of the sponges two 
pieces of Whatman papers were placed and some transfer buffer was poured to soak the 
paper and to remove any air bubbles. The gel was placed facing down on the Whatman 
paper and then the nylon membrane was placed with the cut corner touching the cut 
corner of the gel taking care to ensure no air bubbles. Two Whatman papers and a stack 
of paper towels were placed on top of the membrane. A 500 g weight was placed on the 
paper towels to help overnight capillary transfer. Following day, the membrane was 
washed with 2X SSC (3 M NaCl, 0.3 M Na. citrate, the pH was adjusted with 1N HCl to 
7, and water was added to 1L) for 5 minutes. The membrane was later allowed to dry on a 
Whatman paper for 5 minutes and then cross-linked using the Bio-Rad GS Gene Cross 
Linker at setting C3 (150 m joules). The membrane was wrapped in saran wrap and 
stored in a dry place until use. 
27 
Generation of probes 
These steps were performed essentially as previously described (Daniell et al., 
2004d). The flanking sequence probe was obtained from the plasmid pUC-ct vector that 
contains the chloroplast flanking sequences for the trnI and trnA genes. The digestion 
reaction was setup as follows: 15 μl of pUC-ct vector DNA, 2 μl of 10X buffer, 1 μl of 
BamHI (NEB), 1 μl of BglII and 1 μl of dH2O. The reaction was performed overnight at 
37°C and then run on an agarose gel to obtain the desired fragment of 0.8 kb. The band 
was cut out and eluted from the gel as previously explanied. For the final DNA elution, 
50 μl of H2O was used. The gene-specific probe was made by cutting out the 0.3 kb 
fragment from pBluescript-PyMSP119 in a reaction as follows: 2 μg of pBlue-PyMSP1-
19, 2 μl of 10X buffer, 1 μl of EcoRV (NEB) and 12 μl of dH2O. The reaction was 
incubated overnight at 37°C. The fragment of interest (0.3 kb) was eluted from the 
agarose gel and checked for the concentration on the spectrophotometer. 
Probe labeling 
  The denatured probe (45 μl of the DNA) was made by incubating the tube at 
94°C for 5 minutes, followed by placing the tube immediately on ice for 2 to 3 minutes. 
Following which, the probe was added to the ready mix and mixed well (Quanttm G-50 
Micro columns, Amersham). Five μl of α-32P was added to the tube and the mixture was 
incubated for 1 hour at 37°C. Later, a G50 column was taken and the resin was 
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resuspended by vortexing. The column was placed in a microcentrifuge tube with the top 
cut off and centrifuged for 1 minute at 3,000 rpm. The collection tube was discarded and 
the column was transferred to a new 1.5 ml tube. The DNA probe was added in the center 
of the resin and spun at 3,000 rpm for 2 minutes and the column was discarded. From the 
labeled probe 1 μl was mixed with 98 μl of TE buffer. The mixture was aliquoted into 50 
μl samples and to each sample 3 ml of Opti-Fluor was added. The activity of the 
radioactive probe was measured in a Beckman LS 5000TD. The two samples plus a blank 
containing 3 ml of Opti-Fluor were placed into the machine holder. The readings were 
taken by using the auto-read mode of the machine. The amount of probe to be used was 
determined by calculating the amount of probe needed to yield 2.5 x 106 cpm/2 ml. The 
amount of probe was calculated as follows: Reading value (502050) was equal to 0.50 x 
106 cpm/μl, then multiplied by 50 μl of total volume of sample for a total of 35 x 106 
cpm/μl. Because 5 ml of hybridization solution was used, we needed 6.25 x 106 cpm, 
therefore 6.25 x 106 cpm divided by 0.7 x 106 cpm is equal to 12.5 μl of labeled probe 
needed. 
Prehybridization, hybridization and washing of membrane 
The blot was incubated with 5 ml of Quick-Hyb solution from Stratagene in a 
hybridization bottle with the top facing in toward the solution for one hour at 68°C using 
Fisher Biotech Hybridization Incubator. Later, the probe was added with 100 μl of 
salmon sperm DNA and heated for 5 minutes at 94°C followed by addition of probe to 
29 
the bottle containing the membrane with pre-hybridized solution and incubated for 1 hour 
at 68°C. After that, the membrane was washed twice with 50 ml of wash solution 1 (2X 
SSC and 0.1% SDS) at room temperature for 15 minutes. A second round of washes were 
performed twice with 50ml of wash solution 2 (0.1X SSC and 0.1% SDS) for 15 minutes 
at 60°C to increase the stringency. Finally, the radioactive membrane was wrapped 
around with saran wrap and kept in a radioactive container in the radioactive hood. 
Autoradiography 
The film cassettes with the blots were taken to the dark room and under safe light 
(red light), the X-ray film was placed on the top of the blot with intensifier screen placed 
in between. The cassette with the blot and the film was incubated overnight at –80°C. 
The next day, the cassette was taken out from the –80°C to thaw, and then the film was 
developed. 
 
Characterization of expressed proteins 
Extraction of Protein from Transformed E. coli Cells 
The E.coli XL1-blue cells with pLD-g10-PyMSP119 were grown in 5 ml of 
Terrific broth with ampicillin (100 μg/μl) and tetracycline (50 μg/μl) at 37oC for 14 to 16 
hrs. As a negative control, untransformed E. coli cells were used. After the boiling step 
(as described below), samples were immediately loaded into polyacrylamide gels. About 
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800 μl of cultured cells were centrifuged for 1 minute at 13,000 rpm and the pellet of E. 
coli cells was washed with 1 ml of 1x Phosphate-Buffered Saline (PBS: 140 mM NaCl, 
2.7 mM KCl, 4 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.2) followed by resuspension of the 
pellet in 1X PBS. The sample loading buffer (1.25 ml of 0.5 M Tris-HCl, pH 6.8, 2.0 ml 
of 10%  (w/v) SDS, 0.2 ml of 0.5% (w/v) bromophenol blue, 2.5 ml of glycerol, add 9.5 
ml of distilled water), and β-mercaptoethanol were mixed in 19:1 ratio to prepare 1x 
reducing SDS-loading buffer. Equal amounts of crude extract and 1X reducing-SDS 
sample loading buffer were mixed thoroughly and boiled for 5 minutes. Then, the 
denatured, reduced samples were immediately loaded onto gels. (Sambrook et al.,1989). 
Extraction of Protein from Transformed Tobacco Leaves 
The PyMSP119 protein from transgenic lines was extracted as previously 
described (Daniell et al., 2004d). The plant tissue (100 μg) was ground with a mortar and 
pestle in liquid nitrogen and 200 μl of extraction buffer (100 mM NaCl, 10 mM EDTA, 
200 mM Tris-HCl-pH8, 0.05% Tween-20, 0.1% SDS, 14 mM BME, 400 mM sucrose, 2 
mM PMSF) was added. The samples were mixed for 3 minutes with a micropestle and 
centrifuged at 13,000 rpm for 10 min to obtain the supernatant containing the soluble 
proteins. Twenty μl of these extracts were mixed with 20 μl of sample loading buffer 
containing βME and boiled for 5 minutes to load it on gel for SDS-PAGE. For PAGE, the 
samples were extracted following the similar protocol but without SDS. To maintain the 
native conformation, the samples were not boiled or reduced with βME. 
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SDS-PAGE Buffers and Gels 
  The protein expression of PyMSP119 was detected by conducting SDS-PAGE 
using buffer solutions: Bio-Rad (cat#161-0158), 30% Acrylamide/Bis solution according 
to the ratio 37:5:1, the resolving buffer (5 M Tris-HCl, pH 8.8), the stacking buffer (0.5 
M Tris-HCl, pH 6.8), 10x Electrode buffer: 30.3 g Tris base, 144.0 g glycine and 10.0 g 
SDS were added to 1000 ml double distilled water and stored at 4°C, 2x loading buffer, 
also called Sample buffer or SDS Reducing Buffer (see previous section), 10% (w/v) 
Sodium Dodecyl Sulfate (SDS), N,N,N,N’-Tetra-methyl-ethylene diamine (TEMED) 
from BIO-RAD (cat# 161-0800), 20% Ammonium Persulfate (APS)(dissolved 20 mg of 
APS into 1 ml dH20 in a micro centrifuge tube and stored at 4ºC for about a month). The 
15% resolving gel was made by the following method: 5.0 ml of 30% Acrylamide/Bis, 
2.5 ml of resolving buffer, 2.4 ml dH20 and 100 μl of 10% SDS to a 50 ml flask were 
added. Later, 50 μl of 20% APS (#8 above), 10 μl of TEMED were added to cast the gel 
mixture between the two, vertical, glass plates (Mini-Protean 3 Cell gel system, Bio-Rad) 
leaving about 1.5 cm at the top of glass plates for the stacking gel. The gel was allowed to 
polymerize for 20 minutes. 4% stacking gel was made using 1.3 ml of 30% 
Acrylamide/Bis, 2.5 ml of the stacking buffer, 6.1 ml dH20 and 100 μl of 10% SDS were 
taken together into a flask followed by 50 μl of 20% APS and 10 μl of TEMED. The 4% 
gel mixture was layered on top of resolving gel, and then the comb was inserted for the 
formation of wells. After polymerization for about 20 minutes, the gel was put vertically 
into PAGE apparatus containing 1x Electrode (running) buffer. 20 μl of protein extract 
along with the sample-loading buffer was loaded along with PyMSP119 protein standard, 
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and 10 μl protein marker. The gel was run at 50 V until samples stacked onto the top of 
the resolving gel, then run at 80 V for 2 to 3 hours so that the protein marker bands could 
spread out sufficiently. 
Transfer of protein and analysis of Western Blot 
  The proteins from SDS-PAGE to trans-Blot nitrocellulose membrane (Bio-Rad) 
was done by electroblotting in a Mini-Transfer Blot Module at 80 V for 45 minutes using 
transfer buffer (360 ml of 10x Electrode buffer, 360 ml of methanol, 0.18 grams of SDS, 
1080 ml distilled H20). For Western blotting, nitrocellulose membrane with proteins was 
blocked for one hour in P-T-M (PBS [12 mM Na2HPO4, 3.0 mM NaH2PO4-H2O, 145 
mM NaCl, pH 7.2], 0.5% Tween 20, and 3% Dry Milk) followed by incubation with P-T-
M containing rabbit raised anti-PyMSP1-19 polyclonal antibody (1:1000). Later, 
Membranes were incubated with P-T-M containing goat-derived anti-rabbit IgG antibody 
conjugated with alkaline phosphatase (Sigma, St. Louis, MO). Blots were washed three 
times with PBST for 15 minutes each time followed by 10 min wash in 1X PBS. Finally, 
the membrane was incubated with Lumiphos WB (Pierce, Rockford, IL) as a substrate for 
AP at room temp for 5 min for the chemiluminescence. Then, X-ray films were exposed 
to chemiluminescence and the films were developed in the film processor to visualize the 
bands.  
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Coomassie Staining of the protein gel 
Coomassie staining was performed using the Coomassie dye-250 Brilliant blue 
(Bio-Rad). The concentrated dye was diluted 5 times with distilled water. The SDS-
PAGE protein gel was incubated in the stain for 30 minutes at room temperature followed 
by destaining overnight with destain solution (7% acetic acid, 5% methanol, 88% water) 
at room temperature. 
Enzyme Linked Immunosorbent assay (ELISA) 
ELISA was done to quantify PyMSP119 protein in the plant crude extract. The 
transgenic leaf samples (100 mg) of young, mature, old stages along with wild type leaf 
samples (young, mature, old) were collected.The leaf samples were finely ground in 
liquid nitrogen and extracted in a plant extraction buffer. The protein concentration for 
standards, test samples and antibody were diluted in 1x PBS. Diluting in 1x PBS buffer 
made purified PyMSP119 protein standard ranging from 1 to 25ng/ml. The 96 well ELISA 
plate was coated with standards and protein samples (100 μl) for 1 h at 37oC followed by 
3 washes with PBST and 2 washes with water. Blocking was done with 3% milk in PBS 
and 0.1% Tween and incubated for 1 hour followed by washing. The primary anti-
PyMSP119 antibody (Immuno Chemicals) diluted (1:500) in PBST was added and the 
plate was incubated for 1 hour followed by washing steps. Again, 100 μl of anti-rabbit 
IgG-HRP conjugated antibody raised in goat (American Qualex) (1:5000) diluted in 
PBST was added and the plate was then incubated for 1 hour at 37 °C. After the 
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incubation the plate was washed thrice with PBST and twice with water. The wells were 
then loaded with 100 μl of 3,3,5,5-tetramethyl benzidine (TMB from American Qualex) 
substrate and incubated for 10–15 min at room temperature. The reaction was terminated 
by adding 50 μl of 2 N sulfuric acid per well and the plate was read on a plate reader 
(Dynex Technologies) at 450 nm (Modified form of protocol from Ausubel et al., 4th 
edition). 
Bradford assay for protein quantification  (Bio-rad manual) 
        Extraction buffer was used to make Bovine Serum Albumin (BSA) standards 
ranging from 0.05 to 0.5 μg/μl. Plant extracts were diluted 1:5, 1:10 and 1:20 with 
extraction buffer. Ten μl of each standard and 10 μl of each plant dilution were added to 
the wells of a 96 well microtiter plate (Costar) in duplicate. Bradford reagent (BioRad 
protein assay) was diluted 1:4 with distilled water as specified and 200 μl was added to 
each well. Absorbance was read at 595 nm. Comparison of the absorbance to known 




             The protein expressed in the transgenic plant was purified using Mono-Q 
columns. 10g of plant leaves were finely ground in liquid nitrogen ant crude extract was 
obtained using 20 ml of plant protein extraction buffer (100 mM NaCl, 200 mM Tris-
HCl-pH8, 0.05% Tween-20, 400 mM sucrose, 2 mM PMSF adjusted to pH 9.6). The 
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extract was transferred to a Sorvall tube and centrifuged at 12,500 rpm (20,000 x g) for 
30 minutes and the supernatant was transferred into a new falcon tube .The buffers used 
for purification were as follows: Running buffer (Buffer A): 50 mM Tris-Hcl, 20 mM 
NaCl adjusted to pH 7.5. Elution Buffer (Buffer B): 50 mM Tris HCl and 1 M NaCl. 
Purification operations were performed on the FPLC machine. The running buffer was 
passed into the purification set up through A port, Elution buffer through Port B. The 
purification steps were carried out as follows: Washing the column with running buffer, 
followed by application of sample, followed by washing and gradient elution of sample 
with buffer B. The samples were collected in 1000 ul volume. The samples 
corresponding to the peak were aliquoted for further analysis. The flow through was 
collected to analyze the loss of PyMSP119. The protein aliquots, flow through samples 
were analyzed for the presence/absence of PyMSP119 using western blot. The fractions 
containing the purified PyMSP119 were pooled together and concentrated five fold using 
10K MW concentrator columns (Millipore) by centrifuging at 3000 rpm to concentrate 
the protein and ran through FPLC using superdex columns using similar buffers as 
mentioned above. The fractions were collected in 1ml volume and the samples were 
tested for PyMSP119 by western blot.  
Enrichment of chloroplast-derived PyMSP1-19 
   The plant leaves of 150 grams were finely ground in liquid nitrogen and the 
crude extract was prepared using 300ml of plant extraction buffer (100 mM NaCl, 10mM 
EDTA, 200 mM Tris-HCl-pH8, 0.05% Tween-20, 400 mM sucrose, 2 mM PMSF 
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adjusted to pH 9.6). The extract was transferred to a Sorvall tube and centrifuged at 
12,500 rpm for 30 minutes and the supernatant was transferred into a new falcon tube. 
The total crude extract was lyophilized using a lyophilizer to ten-fold concentrated 
protein. The concentrated crude extract was run on big SDS-PAGE as mentioned earlier 
with all components added in the similar procedure but with three times its actual 
volume. A strip of the gel is tested for protein expression by western blot as mentioned 
earlier and the entire gel was stained with Coomassie dye- 250 Brilliant blue. The desired 
band of PyMSP1-19 protein was excised and eluted using an Electro-eluter (Bio-Rad) 
Elution of PyMSP119 protein from SDS PAGE 
  The PyMSP119 protein was eluted by using Electro-eluter (Bio-Rad protocol). 
The dialysis membrane caps were soaked in 1X elution buffer (Electrode buffer used for 
SDS-PAGE running) for 1 hour at 65ºC before using them for elution. The glass tubes 
were taken and Frit was placed in the bottom of each glass tube. Glass tube with Frit was 
pushed into the electro-eluter module and was positioned evenly with the top of the 
grommet. All empty holes were filled with grommet stoppers. A pre-wetted membrane 
cap was placed in the bottom of each Silicone Adaptor and the adaptor was filled with 
elution buffer( electrode buffer protocol). Then, the Silicone adaptor was slided with the 
membrane cap onto the bottom of the Glass Tube with the Frit and all air bubbles in 
between Frit were removed for proper elution of the protein. The Glass Tube was filled 
with the elution buffer and the sliced gel was placed in the tube. The entire module was 
placed in buffer chamber. The lower buffer chamber was filled with ~600ml of elution 
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buffer and upper buffer chamber with ~100ml. A stir bar was placed in the bottom buffer 
tank for constant stirring to prevent air bubbles from sticking to the bottom of the dialysis 
membrane. Attach lid with cables. Elution was done at 8-10mA/glass. 
 
Immunization studies in mice 
 
 Two Balb/c mice, 6 to 7 weeks old were immunized with enriched chloroplast-
derived PyMSP119 with freund’s adjuvant to raise anti-PyMSP119 antibodies and one 
control mouse (negative) is injected with the wild type crude extract commercially by 
Harlon Bioscience products. The proposed dosage by the company for polyclonal 
antibody production in mice was mentioned in the table below: 
Days Dosage per mouse Bleeds obtained after 
immunization 
0 50μg of enriched PyMSP119  
28 25μg of enriched PyMSP119 
(first boost) 
 
35  Test bleed-0.1ml sera of 
1:10 dilution 
56 25μg of enriched PyMSP119 
(second boost) 
 
70  Final bleed-0.3ml sera and 
ship the animals to us 
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ELISA to detect anti-PyMSP119 antibodies in the serum samples 
 
           96 well ELISA plates were coated with purified Plasmodium yoelii standard 
protein at a concentration of 1μg/ml in phosphate buffer saline solution i.e., 100ng of 
protein per well. The plates were incubated overnight at 4°C. The next day, the plates 
were washed and blocked with PBS containing 0.1%tween and 3% skim milk powder. 
Since the sera obtained were in 1:10 dilution, the serum samples were serially diluted 
ranging from 1:25 to 1:500 for the Bleed-1 and 1:25 to 1:1000 for Bleed-2. Plates were 
incubated with 100 μl of diluted serum samples for one hour at 37°C. Later, the plates 
were washed with PBS-tween(P-T) and water. Subsequently, the plates were incubated 
with 100 μl of 1:5000 diluted goat raised anti-mouse IgG conjugated with horseradish 
peroxidase enzyme for one hour at 37°C followed by washing with P-T. Addition of 100 
μl TMB substrate and incubation of the plate at room temperature until the blue color is 
developed (approximately 10-15 min) was done. The reaction was stopped with 50 μl of 
2M sulphuric acid and the plate was read at 450nm on the plate reader (Dynex 
technologies). The titer values were determined by using the formula O.D (optical 
density) of the negative control (unimmunized mice) + 0.1. 
 
In vitro parasite inhibition assay 
 
         The plasmodium falciparum was used as test parasite for the assay instead of 
Plasomodium Yeolli due the availability of P. falciparum in Dr. Chakrabarti’s lab. A 
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synchronized plasmodium falciparum culture consisting of trophozoite-schizont stage 
parasites with 10% parasitemia and 5% hematocrit was obtained from Dr.Debopam 
Chakrabarti’s lab. The culture was diluted five-fold with RPMI media containing 0.05% 
albumax to obtain 2% parasitemia and 1% hematocrit. Later, 1% fresh human RBC was 
added to the culture. In a 96 well tissue culture plate, duplicates of different samples were 
added as mentioned in the below table: 
S.No. Sample in duplicates Composition per well 
1.        Blank 40µlofculture 
(2%parasitemia+2%hematocrit) + 10 µl of 
RPMI media 
2. Negative control 40µl of culture 
(2%parasitemia+2%hematocrit) 
+ 10µl of sera obtained from mice 
immunized with wild type crude extract. 
3. PyMSP119 40µl of culture 
(2%parasitemia+2%hematocrit) 
+10µl of sera obtained from mice immunized 
with chloroplast-derived PyMSP119
4.  Positive control 47.5µl of culture (2%parasitemia+2% hem-
atocrit) 
+2.5µl of purified anti-PfMSP119 antibodies 
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The plate was incubated at 37◦C for 48 hours as the parasite completes one cycle and 
invasion of the RBC. After incubation, the plate was taken out and thin blood smears 
were prepared on slides. The slide was stained using hemastain kit (from sigma Aldrich 
protocol) and observed under normal light microscope (X100 objective). Up to 200-300 
red blood cells were counted manually and average parasitemia was measured using the 
formula (infected red blood cells/ infected+uninfected red blood cells) x 100. Later, the 
pictures were taken from all the slides to show the extent of parasitemia under light 
microscope. 
 
ELISA of Plasmodium falciparum MSP119 coated plates using sera obtained from   
mice immunized with chloroplast-derived PyMSP119 
 
       96 well plate was coated with 1 µg/ml of purified PfMSP119 antigen overnight at 
4◦C. The next day, the plate was washed with 1x PBS and 0.1% tween followed by 
blocking in 3% P-T-M at 37◦C for an hour. Then, after similar washing as mentioned 
earlier, the plate was incubated with 1:10 diluted anti- PyMSP119 antibodies using three 
different dilutions 1:25, 1:50, 1:100. The remaining steps were all similar as mentioned in 







In vivo parasite challenge in immunized mice
a. Plasmodium yoelii infection to BALB/c mice 
       The frozen stock of 17XL (Lethal) strain of P.yoelii (a kind gift from Drexel 
Company) was used in parasite challenge studies. The infected RBC with 17XL strain 
was thawed by adding1ml Hank’s Balanced Salt solution buffered with 0.02M HEPES 
pH 7.2-7.4 and shaking quickly with hand. Within 15min, the stabilite was drawn into a 
1.0ml tuberculin syringe and injected into the normal 6-8 weeks old Balb/C mice with 
100 μl each at two different sites via intraperitoneal route. The parasitemia was 
monitored every alternate day by collecting few drops of blood by snipping the mouse 
tail off and making smears on the slides. The smear was stained with hema-stain and the 
number of infected red blood cells was counted under a light microscope.  
 
b. Parasite challenge into immunized mice 
    When the parasitemia in the infected mice reached 70-80%, the blood was collected 
from the heart of the mouse by performing a cardiac puncture. About 400-500 μl of blood 
was drawn and diluted in 1:1 with 20% glycerol, 20mM HEPES pH 7.4 in Hank’s 
balanced salt solution containing 50units/ml Heparin. Immediately after diluting, 100 μl 
of 35-40% parasitemia was injected via i.p. into the two immunized mice and one control 
inimmunized mouse. The infection was monitored in all three mice as discussed above. 
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The remaining stabilite was aliquoted into 0.1ml in freezing vials and stored in Styrofoam 













The pLD vector contained the flanking sequences, which ensured the homologous 
recombination of the gene cassette (aadA, g10-PyMSP119) between the trnI and trnA 
genes of the chloroplast genome (Daniell et al., 2001a). Downstream of trnI, the vector 
provided the constitutive 16S rRNA promoter, which regulates the expression of aadA 
gene (aminoglycoside 3’ adenyltransferase) that confers resistance to spectinomycin and 
streptomycin (Goldschmidt-Clermont, 1991), and the PyMSP119 gene encoding the 
merozoite surface protein. On the other hand, the vector contains the 3’UTR downstream 
of trnA gene, which terminates and stabilizes the transcripts derived from psbA gene. 
 
PCR analysis of Confirmation of Chloroplast integration of transgenes 
 
We obtained about 10 resistant shoot after a period of 3 to 5 weeks on  
regeneration media (RMOP) containing spectinomycin. To differentiate the chloroplast 
integrated shoots from nuclear integrated and mutant shoots, specific primers were used 
to perform PCR. A spontaneous mutation in the 16s RNA gene confers resistance to 
spectinomycin and could allow the shoots to grow without integration of the gene 
cassette and the aadA gene in the gene cassette confers resistance to spectinomycin 
(Daniell et. al., 2001a). The site-specific integration of the gene cassette with chloroplast 
genome was confirmed using 3P/3M primers (Daniell et.al., 2001a). The 3P primer 
annealed to the native chloroplast genome, eliminating all nuclear transformants, and 3M 
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landed on the aadA gene, eliminating all mutant transformants (fig 1a).The amplified 
PCR product with 3P/3M primers yielded ~1.65Kb band (fig 1b). 
The integration of aadA and g10-PyMSP119 were tested with a another set of 
primers for PCR analysis, 5P/2M. 5P annealed to the aadA gene and 2M annealed to the 
integral part of trnA region (fig 1a) (Daniell et al 2001a). From 5P/2M primers, the 
amplified PCR product was ~1.9kb size (fig 1c), confirming the integration of gene 
within the chloroplast genome and eliminating the mutants as they would amplify at all. 
The positive transgenic plants were subjected different rounds of selection until they 
attained homoplasmy. 
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Figure 1: PCR analysis of Wild type and putative transformants of pLD-g10- PyMSP119 
1A) PCR using specific primers land within the native chloroplast genome (3P/3M) to 
yield a 1.65 kb product and 5P/2M primers landing on aadA and trnA respectively to 
yield 1.9 kb product 1B(3P/3M): Lane 1-4: Trangenic lines pLD-g10- PyMSP119, Lane 
5: Positive control (transgenic line pLD-g10-Lec A), Lane 6: Wild type, Lane 7: 1 kb 
DNA ladder  1C(5P/2M): Lane 1-5:Transgenic lines pLD-g10- PyMSP119, Lane 6: 
Positive control (transgenic line pLD-g10-Lec A), Lane7: Wild type, Lane 8: 1kd DNA 
ladder  
 
Southern Analysis of transgenic plants 
 
To confirm the site-specific integration, the transgenic plant DNA was probed 
with the flanking sequence probe of 0.81 kb in size (fig. 2a) with BamHI and BglII 
(Daniell et al., 2001a). The transformed chloroplast genome digested with BglII produced 
a fragment of 6.4 kb, while the untransformed chloroplast genome gave a 4.47 kb 
fragment (fig. 2b). Some of the transgenic PyMSP119 lines showed slight degrees of 
heteroplasmy as few of the wild type genomes were not transformed. The gene-specific 
46 
probe of about 0.34 kb was used to show the integration of gene within the chloroplast 
and eliminated nuclear transformants as they would give a different size band. (fig. 2c) 
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  Figure 2: Southern blot analysis of pLD-g10- PyMSP119
Schematic diagram of expected products from digestion of (2a) wild type untransformed 
plant and Plants transformed with pLD-g10- PyMSP119 (2b) Southern with flanking 
sequence probe in pLD-g10- PyMSP119 transgenic lines showing slight heteroplasmy: 
Lane1: wild type, Lanes 2-5: Transgenic lines 2c) Southern with PyMSP119 gene specific 
probe showing the presence of PyMSP119 in the transgenic plants: Lane 1: Ladder, Lanes 
2-6: pLD-g10- PyMSP119 transgenic lines, 7-Blank, 8-Wild type. 
 
   Immunoblot Analysis 
 
Crude extracts of approximately 40 μg was loaded in each well to perform SDS-
PAGE. The western blot with anti-PyMSP119 antibodies detected the PyMSP119 protein 
that showed a 17 kDa size protein under denaturing conditions (fig.3) 
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Figure 3 19 in transgenic plant 
ne1: Wildtype, Lanes 2-4: 
f transgenic lines Lane 5: ladder, Lane 6: 250ng of GST- PyMSP119 
    1     2       3        4          5         6 3 
 
: Western blotting demonstrating the expression of PyMSP1
crude extracts under reducing conditions(SDS-PAGE) :  La
17kDa 
40ug crude extract o
as positive control(36kDa).  
 
Protein quantification using ELISA 
 
 To quantify the protein levels, the standard protein (PyMSP119) of known 
concentration were optim pression levels of pLD-
g10- PyMSP119 plant of T0 generation reached up to 2% of total soluble protein (TSP) in 
mature
 
ized (Fig 4a). The PyMSP119 protein ex
 leaves, 1% of TSP in old leaves and 0.54% of TSP in young leaves  (fig. 4b).The 
large contribution of PyMSP119 was from the mature leaves, due to the presence of high 
number of chloroplasts and the high copy number of chloroplast genomes (up to 10,000 
copies per cell), which resulting in very high levels of PyMSP119 expression in mature 
leaves. 
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Note:  No of times the experiment was repeated (n=3) 
In each experiment: - no of replicates are 2(replicates=2) 
 
 
P119 in T0 generation 
(b) Expression levels in %TSP of PyMSP119 expressing leaves (Young, Mature and 
Old).  
e extract 
         
Figure 4: Quantification of expression of level of PyMS
(a) Standard curve for ELISA quantification 
Note: %TSP is calculated = TSP of PyMSP119 protein        X 100 
                                              TSP of total crud
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Enrichment of chloroplast-derived PyMSP119 
A. Using Mono-Q and Superdex columns by FPLC 
he PyMSP119 protein was eluted using Buffer B in a 25% gradient manner (fig. 
5a). PyMSP119 prot ). Some amount of 
protein was observed in flow through as well. All 8 fractions with flow through were 
pooled and loade entrated protein. 
The concentrated protein was then run through superdex column to separate the protein 
        T
ein was eluted at 25% Buffer B in 8 fractions (4-10
d onto 10K MW protein concentrator to obtain conc
based on its molecular weight (fig. 5b). All the fractions were collected and the alternate 
samples were tested with immunoblot. Since the expression levels of PyMSP119 protein 
was low and the amount of protein obtained at the end of the purification was not 





                   
              MSP1 Mono Q-Column 
5a 
1Elution peak  
   
 
             




                                        
52 
Figure 5: Enrichment of chloroplast-derived PyMSP119 by Mono-Q and Superdex 
columns by FPLC method 
5a: 1. Elution peak where PyMSP119 protein was eluted using Mono-Q column Fig 5b: 1. 
Elution peak where PyMSP119 protein was eluted using superdex column. 
B. Using Lyophilizer and Electro-elutor 
 
       The immunoblot assay was performed on the concentrated protein. The blot showed 
a 17kDa PyMSP119 protein which was used as guidance to excise the corresponding band 
from the coomassie stained SDS-PAGE. The PyMSP119 protein was eluted from the gel 
using an electro-eluter. The eluted protein was quantified by western blot using a 




     
25kDa 6a
1 2 3 4 5 6 7 8 9 10
       
15kDa 
17kDa 
 After Protein Elution 
 
53 
Figure 6: Westerns of eluted PyMSP1-19 protein: Lanes: 1-4 different concentrations of 
positive control GST-PyMSP1-19 (50ng/ul, 100ng/ul, 200ng/ul and 250ng/ul 
respectively). Lane5- wildtype, Lane6-ladder, Lane7-10-eluted PyMSP119 protein. 
 
 
Immunization in mice 
 
       The first test bleeds for two immunized mice and one-control mice were sent at 
0.1ml volume each at 1:10 dilution. The serum was tested for anti- PyMSP119 antibodies 
by conducting ELISA. Mouse#1 was showing higher immune response with IgG titers of 
1:2500 than mouse#2 with IgG titers of 1:1000 (Fig. 7a). After the final boost, the 
immunized mouse-1 showed 1:7000 IgG titers whereas immunized mouse-2 showed a 
titer of 1:4000 (Fig. 7b).The control mouse injected with wild type crude extract did not 
show any significant anti- PyMSP119 IgG titers. 
Figure: 7a 
                                   
ELISA with sera obtained from mice 

















No of times the experiment was performed (n=3) 









































Number of times the experiment was repeated (n=3) 
No. of replicates per experiment (r=2) 
Figure 7: ELISA for the detection of anti- PyMSP119 antibody titers from serum samples 
collected 7 days after the first boost. Immune response between two mice is shown. Also 
the table is given to show the statistics. 
 
In vitro Plasmodium falciparum inhibition assay with anti- PyMSP119 sera 
 
        To test the ability of anti-PyMSP119 antibodies in inhibiting the parasite entry into 
the red blood cells, an in vitro assay was conducted.  After the incubation with 
synchronized Plasmodium falciparum culture (2% parasitemia and 2% hematocrit) and 
trophozoite-schizont stage infected RBC’s (fig. 8a) for 48 hours, the parasitemia was 
estimated. The percentage of parasitemia = number of infected cells/ number of infected 
cells+ number of uninfected cells. The experimental investigations showed that the 
percentage of average parasitemia with anti-PyMSP119 antibodies was very similar with 
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the negative control (sera from mice immunized with wild type crude extract) and higher 
than the blank (untreated but incubated culture with media) (fig. 8b), indicating the 
failure of parasite inhibition into red blood cells by anti-PyMSP119 antibodies (Table 1). 
Also, the red blood cells treated with anti-PyMSP119 antibodies and the sera of wild type 
crude extract predominantly showed stressed late-trophozoites to early schizonts(fig 8c 
and 8d) as opposed to the positive control (treated with anti- PfMSP119), which showed 
100% protection from parasite attack (fig 8e). The failure of parasitic inhibition could be 
attributed to the lack of cross reactivity across plasmodium Sp. (Between yoelli and 
falciparum).  
 









Blank(RPMI) 12/254.Mostly consisted 
of rings and early 
trophozoites in infected 
RBC 
14/286.Predominently 
consisted of rings and 







35/300. Mostly stressed 
trophozoites were seen 
in infected RBC 
19/223. Infected RBC 
were with stressed 
trophozoites 
10.3% 
Anti-PyMSp119 26/237.Moslty stressed 16/220.Stressed 9.2% 
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a) pre-treatment b) Blank –RPMI treated          
                                  
             c) Anti-PyMSP119 treated       d) Treated with un-immunized sera 
                                      




  e) Anti-PfMSP119 treated 
     
Figure 8: In vitro Plasmodium falciparum parasite inhibition assay using sera 
obtained from mice immunized with chloroplast-derived PyMSP119
a)  Synchronized pretreated healthy and infected RBC consisting of trophozoites and 
schizonts. 
b) Untreated culture consisting of uninfected and infected RBC with rings and early 
trophozoites- treated as blank 
c) Treated with sera from the mice immunized with chloroplast-derived 
PyMSP119.Infected RBC mostly consisted of late trophozoites and early 
schizonts. 
d) Treated with sera obtained from mice immunized with wild type crude extract. 
Infected cells showed late trophozoites 
e) Treated with anti-PfMSP119 antibodies as a positive control. No infected cell was 
seen. 
     Arrows- represents the infected red blood cells. Lines- indicate the oil smear. 
 
ELISA of PfMSP119 coated plates with anti- PyMSP119 antibodies 
 
          Since the in vitro assay with anti-PyMSP119 antibodies was not successful, we have 
decided to test whether the sera obtained from the mice immunized with chloroplast-
derived PyMSP119 cross reacts with MSP119 antigen of Plasmodium falciparum.  The 
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ELISA results showed that the average O.D values (0.123) obtained with sera from mice 
immunized with chloroplast-derived PyMSP119 were not significantly different from the 
O.D. values (0.117) obtained from negative control. Thereby, showing that anti-
PyMSP119 antibodies were not cross-reacting with the MSP119 antigen of Plasmodium 
falciparum. 
  
In vivo P.yoelii challenge into immunized mice 
 
           After challenging the immunized mice and control mouse with infected red blood 
cells, the percentage parasitemia for all three mice was monitored for every alternate day 
by collecting blood as described in Material and methods. The percentage parasitemia for 
immunized mouse-1 was 0.53%, 4.6%, 39.1%, 57.6% on day 3, 5, 7, 9 respectively after 
post-infection whereas IM-2 showed 0.39%, 20.1% on day3 and 5 respectively. The 
unimmunized control mouse showed 0.97%, 20.4%, 78.3% parasitemia on day 3, 5, 7 and 
9 respectively after post-infection (Table 2). The days of survival of immunized mouse-1 
were 10 days as opposed to immunized mouse-2 (8 days), while the unimmunized control 
mouse survived for 9 days. There is inverse correlation between between the parasitemia 
and the antibody titers.  
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 Table2: Percentage parasitemia of immunized mice after challenge with P.yoelii infected 








3 0.53% 0.39% 0.97% 
5  4.6% 20.1% 20.4% 
7 39.1% Died 78.3% 
9 57.6%  Died 













The main objective of expressing PyMSP119 antigen in chloroplast system using 
biolistic method was to develop a safer vaccine in plants and also the rodent model was 
used to establish a human malaria vaccine eventually. The final chloroplast pLD vector 
with pLD-g10- PyMSP119 cassette was integrated into the chloroplast genome via 
homologous recombination of trnA and trnI flanking sequences. The transcription and 
translation of PyMSP119 gene was regulated by 16srRNA promoter and bacteriophage 
5’UTR-g10 with a ribosomal binding region respectively. The 3’UTR region downstream 
the gene stabilizes the transcripts. The integration of the cassette into the chloroplast 
genome was selected under 500mg/l of spectinomycin antibiotic pressure. Due to the 
presence of the aadA gene that encodes for the enzyme aminoglycoside 3’ 
adenyltransferase in the pLD vector (Daniell et al., 2001a, Svab and Maliga, 1993), the 
plant cells with pLD-g10- PyMSP119 cassette would overcome the spectinomycin 
selection pressure. The viable cells undergo cell division along with the chloroplast 
genome including the pLD-g10 -PyMSP119 sequence. The integration of the gene within 
chloroplast genome was confirmed by PCR using 3P/3M and gene-specific primers. 
However, under the influence of the resistance developed by aadA gene product there 
will be simultaneous regeneration of wild type cells. As a result, the first round of 
selection would still contain both wild type and transgenic cells in the viable tissue. 
Therefore, the transgenic leaf tissues were subjected to second round of selection by 
placing them on a regeneration media containing 500mg/l spectinomycin. 
       The percentage of homoplasmy within the transgenic lines of pLD-g10- PyMSP119 
was tested by performing southern analysis using flanking and gene-specific sequences as 
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probes. Although, a slight degree of heteroplasmy was seen in the transgenic lines, the 
presence of transformed genome was higher than the wild type genome and the complete 
transformation of wild type genome is expected by next generation (T1).    
         The translation of PyMSP119 gene was ensured by bacteriophage 5’UTR-g10 with 
ribosomal binding region and the expression of PyMSP119 protein was confirmed by 
western blot. The protein was seen at 17kDa size under denaturing conditions. Upon 
quantification, the PyMSP119 protein levels were 1.5-2% of TSP (Fig 5) The expression 
levels obtained were 1000 fold higher than the nuclear expressed PyMSP119 (Ghosh et 
al., 2002). Although the expression levels of the protein in chloroplast were significantly 
higher than the nuclear expressed protein, compared with other chloroplast-derived 
vaccine antigens such as anthrax protective antigen-14%(Koya et al., 2005), CTB-33% 
(De cosa et al.,2001), Tetanus antigen-25%( Tregoning et al., 2003), the expression 
levels of PyMSP119 were very low. These low levels of PyMSP119 protein expression 
could be attributed to the absence of light-regulated 5’UTR- psbA promoter. The cloning 
of PyMSP119 gene with 5’UTR-psbA promoter was difficult and therefore, it had to be 
replaced with 5’ UTR-bacteriophage g10. Since, the bacteriophage-g10 sequence consists 
of only ribosomal binding region and do not contain the promoter sequence, it will not 
hyper-express the gene but only ensures its proper translation.  
        Due to low levels of protein expression, the enrichment procedure was done for 
several rounds and also the functional studies had to be limited to two mice.100 μg of 
enriched protein was injected in two mice and anti-sera obtained from these mice were 
tested for anti- PyMSP119  antibodies using yeast expressed PyMSP119 protein. The titers 
obtained for immunized mouse-1 were 1:7000 and for immunized mouse-2 were 1:4000. 
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To prove the functionality of PyMSP119 gene, the in-vitro P.falciparum inhibition assays 
were performed based on the rationale of sequence homology (30%) between P.yoelii 
and P.falciparum (Fig 10). The expected outcome of the assay was the inhibition of 
P.falciparum invasion into the RBC, by the anti-sera. However, the parasite inhibition 
was not observed in in vitro assays. This could be attributed to the lack of cross reactivity 
between the anti-sera and P.falciparum MSP119. This was further confirmed by 
performing ELISA with anti-sera from the first bleed, where no cross reactivity was 
observed between anti-sera and P.falciparum antigen. Therefore, the in vivo experiments 
were carried out to test the functionality of anti- PyMSP119 antibodies developed against 
chloroplast-derived PyMSP119. 
 
Figure 9: Homology between the C-terminal portion of Plasmodium yoelii(Py230)  and 
Plasmodium falciparum (PF195) MSP1. Courtesy from Burns et al., 1988 
        The immunized mice were subjected to parasite challenge. When compared with 
unimmunized control mouse, the percentage parasitemia for immunized mouse-1 on day 
5 after post-infection was five fold lower (4.6% parasitemia in IM-1 and 20.4% in 
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unimmunized control mouse) and two fold lower (39.1% in IM-1 and 78.3% in Mc) on 
day 7 after post-infection. On the other hand, the percentage parasitemia in immunized 
mouse-2 were parallel with unimmunized control mouse. This relative difference in 
parasitemia between immunized mouse-1 and immunized mouse-2 could be inversely 
correlated with the relatively higher immune titers of immunized mouse-1(1:7000) and 
relatively lower immune titers of immunized mouse-2(1:4000). The days of survival of 
immunized mouse-1 were 10 days as opposed to immunized mouse-2 (8 days), while the 
unimmunized control mouse survived for 9 days. However, for effective 
immunoprotective titers the dose protocol needs to be optimized with larger animal group 
to make a concrete conclusion.   













The C-terminal 19kDa merozoite surface antigen of Plasmodium yoelii has been 
expressed in chloroplast system for the first time successfully. Due to 65% homology 
between the amino acid sequence of Plasmodium falciparum and Plasmodium yoelii 
(Burns et al., 1988), the production of chloroplast-derived PyMSP119 transgenic plants 
could create hope for developing a low cost human malaria vaccine in plants, which will 
eliminate some of the major constraints such as laborious purification techniques, 
extensive storage facilities and high technical skills. 
The site-specific integration of PyMSP119 gene within chloroplast genome was 
confirmed by PCR using specific primers and the degrees of homoplasmy was measured 
by southern blot. To ensure proper expression of the transgene, immunoblot blot using 
anti- PyMSP119 antibodies was performed, where a 17kDa protein was detected under 
denatured, reduced conditions. The expression levels of PyMSP119 protein was detected 
by ELISA using anti-PyMSP119 antibodies and they showed a maximum expression of 
about 2% of TSP in mature leaves.  The immunization studies in mice confirm that the 
chloroplast-derived PyMSP119 is immunogenic in nature as it elicited 1:2500 anti- 
PyMSP119 IgG titers with the sera collected from 7 days after first boost in mice. 
Although, the in vitro Plasmodium falciparum parasite inhibition assay was not 
successful with anti- PyMSP119 antibodies, the lack of cross reactivity between the two 
species explained the experimental outcome. The in vivo studies suggested that there was 
an inverse correlation between the parasitemia and the immune titers. However, concrete 
conclusions can be made with the studies using larger animal groups.  
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